{"id":"https://openalex.org/W77663947","doi":null,"title":"GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties.","display_name":"GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties.","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W77663947","mag":"77663947","pmid":"https://pubmed.ncbi.nlm.nih.gov/1324586"},"language":"en","primary_location":{"id":"pmid:1324586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1324586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in biochemical psychopharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106235440","display_name":"Hanns M\u00f6hler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"H Mohler","raw_affiliation_strings":["Institute of Pharmacology, University of Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, University of Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019643013","display_name":"Dietmar Benke","orcid":"https://orcid.org/0000-0003-1846-4711","observed_orcids":["https://orcid.org/0000-0003-1846-4711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Benke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109814252","display_name":"S. Mertens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Mertens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052503226","display_name":"Jean\u2010Marc Fritschy","orcid":"https://orcid.org/0000-0002-8552-3702","observed_orcids":["https://orcid.org/0000-0002-8552-3702"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Fritschy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3694,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.49030761,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"47","issue":null,"first_page":"41","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabaa-receptor-subtypes","display_name":"GABAA receptor subtypes","score":0.8379999995231628},{"id":"https://openalex.org/keywords/alpha1-subunit","display_name":"alpha1 subunit","score":0.7990000247955322},{"id":"https://openalex.org/keywords/alpha3-subunit","display_name":"alpha3 subunit","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alpha5-subunit","display_name":"alpha5 subunit","score":1.0},{"id":"https://openalex.org/keywords/benzodiazepine-receptor-binding","display_name":"benzodiazepine binding","score":0.7540000081062317},{"id":"https://openalex.org/keywords/flumazenil-binding","display_name":"flumazenil binding","score":0.6800000071525574},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.7739999890327454},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.7200000286102295},{"id":"https://openalex.org/keywords/receptor-pharmacology","display_name":"receptor pharmacology","score":0.5400000214576721},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.7658200263977051},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.7217845916748047},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.6882942914962769},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.6551388502120972},{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.5933911204338074},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5623649954795837},{"id":"https://openalex.org/C83730767","wikidata":"https://www.wikidata.org/wiki/Q24778884","display_name":"G alpha subunit","level":4,"score":0.5471977591514587},{"id":"https://openalex.org/C2781442855","wikidata":"https://www.wikidata.org/wiki/Q62947","display_name":"Flunitrazepam","level":4,"score":0.5343512892723083},{"id":"https://openalex.org/C2909005528","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand Assay","level":3,"score":0.5310248136520386},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4437538981437683},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43531349301338196},{"id":"https://openalex.org/C9224880","wikidata":"https://www.wikidata.org/wiki/Q798179","display_name":"GABAA-rho receptor","level":4,"score":0.4126339554786682},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.4063815176486969},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4023946523666382},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34129858016967773},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.30089545249938965},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18697530031204224},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1324586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1324586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in biochemical psychopharmacology","raw_type":"Journal Article"},{"id":"mag:77663947","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1324586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4000000059604645,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1657090468","https://openalex.org/W2001295380","https://openalex.org/W1968479246","https://openalex.org/W1975190206","https://openalex.org/W2002828957","https://openalex.org/W2337967379","https://openalex.org/W1528269719","https://openalex.org/W1998277191","https://openalex.org/W2161745238","https://openalex.org/W1898611792"],"abstract_inverted_index":{"GABAA-receptor":[0],"subtypes":[1,146],"in":[2,74,92,147],"rat":[3],"brain":[4,113],"were":[5,46,87,104],"characterized":[6],"using":[7],"anti-peptide":[8],"antisera":[9],"specific":[10],"for":[11,106,144],"the":[12,35,39,43,78,93,97,107],"alpha":[13,15,18,25,40,44,94,98,108,122,125],"1-,":[14],"3-":[16,41,95],"and":[17,42,50,68,85],"5-subunits.":[19],"While":[20],"a":[21,115],"high":[22],"abundance":[23],"of":[24,33,80,118,134],"1-containing":[26],"receptors":[27,36,119],"was":[28],"demonstrated":[29],"by":[30,63],"immunoprecipitation":[31],"(80-90%":[32],"receptors),":[34],"precipitated":[37],"with":[38,141],"5-antiserum":[45],"less":[47],"frequent":[48],"(18-25%":[49],"10-23%,":[51],"respectively).":[52],"The":[53],"three":[54],"receptor":[55,145],"populations":[56],"displayed":[57,70],"unique":[58],"pharmacological":[59],"properties":[60],"as":[61],"shown":[62],"radioligand":[64],"binding.":[65,76],"Diazepam,":[66],"flumazenil":[67],"flunitrazepam":[69],"similar":[71],"displacing":[72],"potencies":[73],"[3H]-flumazenil":[75],"However,":[77],"affinities":[79,143],"CL":[81],"218872,":[82],"beta":[83],"CCM":[84],"zolpidem":[86],"up":[88],"to":[89,137],"10-fold":[90],"lower":[91],"than":[96],"1-receptor":[99],"population":[100],"while":[101],"intermediate":[102],"values":[103],"found":[105],"5-receptor":[109],"population.":[110],"In":[111],"many":[112],"areas,":[114],"neuron-specific":[116],"expression":[117],"containing":[120],"either":[121],"1-":[123],"or":[124],"3-subunits":[126],"could":[127],"be":[128,133],"visualized":[129],"immunohistochemically.":[130],"It":[131],"will":[132,149],"major":[135],"interest":[136],"determine,":[138],"whether":[139],"ligands":[140],"differential":[142],"situ":[148],"provide":[150],"novel":[151],"therapeutic":[152],"profiles.":[153]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}